Levetiracetam alleviates cognitive decline in Alzheimer’s disease animal model by ameliorating the dysfunction of the neuronal network

BACKGROUND: Patients with Alzheimer’s disease (AD) have a significantly higher risk of seizures than other individuals in an age-matched population, suggesting a close association between epilepsy and AD. We aimed to examine the effects of levetiracetam (LEV)—a drug for treating seizures—on learning...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Xiang-Yu, Zhang, Hai-Chen, Lv, Yu-Dan, Jin, Feng-Yan, Wu, Xiu-Juan, Zhu, Jie, Ruan, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452890/
https://www.ncbi.nlm.nih.gov/pubmed/36092803
http://dx.doi.org/10.3389/fnagi.2022.888784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452890/
https://www.ncbi.nlm.nih.gov/pubmed/36092803
http://dx.doi.org/10.3389/fnagi.2022.888784

Ejemplares similares